LGM
Logos Global Management Portfolio holdings
AUM
$749M
This Quarter Return
+61.99%
1 Year Return
+18.94%
3 Year Return
+431.72%
5 Year Return
+481.1%
10 Year Return
–
AUM
$1.15B
AUM Growth
+$1.15B
(+47%)
Cap. Flow
+$1.54M
Cap. Flow
% of AUM
0.13%
Top 10 Holdings %
Top 10 Hldgs %
68.94%
Holding
74
New
27
Increased
4
Reduced
18
Closed
15
Top Buys
| 1 |
Olema Pharmaceuticals
OLMA
|
$180M |
| 2 |
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
|
$22.7M |
| 3 |
Apellis Pharmaceuticals
APLS
|
$17.2M |
| 4 |
Aligos Therapeutics
ALGS
|
$16.8M |
| 5 |
C4 Therapeutics
CCCC
|
$15.8M |
Top Sells
| 1 |
Keros Therapeutics
KROS
|
$81.1M |
| 2 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$46.9M |
| 3 |
TG Therapeutics
TGTX
|
$46.8M |
| 4 |
Sarepta Therapeutics
SRPT
|
$38.6M |
| 5 |
Nkarta
NKTX
|
$22.4M |
Sector Composition
| 1 | Healthcare | 98.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
ALX Oncology
ALXO
$62.7M
| $272M | 23.33% | 3,156,981 +20,000 | +0.6% | +$1.72M |
|
|
2
Olema Pharmaceuticals
OLMA
$375M
| $180M | 15.43% | +3,743,875 | New | +$180M |
|
|
3
Nkarta
NKTX
$151M
| $103M | 8.86% | 1,682,178 -365,000 | -18% | -$22.4M |
|
|
FMTX
4
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $48.9M | 4.19% | 1,400,000 +226,812 | +19% | +$7.92M |
|
|
5
TG Therapeutics
TGTX
$4.65B
| $44.2M | 3.79% | 850,000 -900,000 | -51% | -$46.8M |
|
6
Dyne Therapeutics
DYN
$1.92B
| $33.7M | 2.89% | 1,604,392 | – | – |
|
7
Athira Pharma
ATHA
$15.3M
| $32.5M | 2.78% | 947,873 -72,939 | -7% | -$2.5M |
|
|
8
Keros Therapeutics
KROS
$618M
| $31.7M | 2.72% | 450,000 -1,150,000 | -72% | -$81.1M |
|
9
Repare Therapeutics
RPTX
$71.7M
| $23.2M | 1.99% | 676,894 -300,000 | -31% | -$10.3M |
|
|
KNTE
10
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $22.7M | 1.94% | +569,602 | New | +$22.7M |
|
11
Cogent Biosciences
COGT
$1.69B
| $21.6M | 1.85% | 1,920,500 -779,500 | -29% | -$8.75M |
|
12
BioXcel Therapeutics
BTAI
$59M
| $19.9M | 1.7% | 430,000 -120,000 | -22% | -$5.54M |
|
|
13
Apellis Pharmaceuticals
APLS
$3.48B
| $17.2M | 1.47% | +300,000 | New | +$17.2M |
|
14
Avidity Biosciences
RNA
$5.99B
| $17.1M | 1.47% | 671,454 -50,000 | -7% | -$1.28M |
|
|
15
Aligos Therapeutics
ALGS
$73.3M
| $16.8M | 1.44% | +606,548 | New | +$16.8M |
|
|
16
C4 Therapeutics
CCCC
$185M
| $15.8M | 1.36% | +477,928 | New | +$15.8M |
|
17
Larimar Therapeutics
LRMR
$310M
| $15.3M | 1.31% | 715,000 +385,000 | +117% | +$8.24M |
|
|
CMPS
18
Compass Pathways
CMPS
$424M
| $14.3M | 1.23% | 300,000 -200,000 | -40% | -$9.53M |
|
19
ARS Pharmaceuticals
SPRY
$1.15B
| $13.9M | 1.19% | +300,000 | New | +$13.9M |
|
|
IGMS
20
DELISTED
IGM Biosciences
IGMS
| $13.2M | 1.14% | +150,000 | New | +$13.2M |
|
|
KRTX
21
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $12.2M | 1.05% | +120,000 | New | +$12.2M |
|
22
AbCellera Biologics
ABCL
$1.25B
| $12.1M | 1.03% | +300,000 | New | +$12.1M |
|
|
MRTX
23
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $11M | 0.94% | +50,000 | New | +$11M |
|
|
CALT
24
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
| $10.1M | 0.86% | 300,000 -250,000 | -45% | -$8.41M |
|
25
Curis
CRIS
$20.9M
| $9.83M | 0.84% | +1,200,000 | New | +$9.83M |
|